Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr James Liu

Dr James Liu

James Liu


Postdoctoral Research Fellow

James was awarded a Novo Nordisk Postdoctoral Research Fellowship to work with Prof Zhengming Chen (Oxford Population Health) and Dr Joanna Howson (Novo Nordisk Research Centre Oxford) in December 2022.

His research focusses on triangulating and investigating the molecular phenotype and mechanism of type 2 diabetes (T2D) applying various epidemiological approaches (e.g., genetic epidemiology methods, Mendelian randomisation (MR) analysis, traditional epidemiology methods) across diverse populations (e.g., UK population and Chinese population), which might provide both public health and therapeutic insights on T2D prevention/treatments.

James underwent medical training (Preventive Medicine) in Sun Yat-sen University, China (2010 - 2015). He subsequently completed his PhD degree in Epidemiology from The University of Hong Kong under the supervision of Prof Gabriel Leung, and Dr C. Mary Schooling (2015 – 2019) examining the associations across birth weight, liver function, and T2D/cardiovascular diseases.

Prior to Oxford, I worked as a senior research associate in the MRC/IEU, University of Bristol (2019 – 2022) mentored by Prof Deborah Lawlor, Prof Martin Rutter, and Prof Jack Bowden investigating the effects of sleep disorders (e.g., lack of sleep, insomnia, evening chorotype) on T2D risk with the use of MR methods.